financetom
Business
financetom
/
Business
/
McCormick's Fiscal Q4 Adjusted Earnings Decline, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
McCormick's Fiscal Q4 Adjusted Earnings Decline, Revenue Increases
Jan 23, 2025 4:09 AM

06:55 AM EST, 01/23/2025 (MT Newswires) -- McCormick & Company ( MKC ) reported fiscal Q4 adjusted earnings Thursday of $0.80 per diluted share, down from $0.85 a year earlier.

Analysts polled by FactSet expected $0.77.

Revenue for the quarter ended Nov. 30 was $1.80 billion, compared with $1.75 billion a year earlier.

Analysts surveyed by FactSet expected $1.77 billion.

For fiscal 2025, the company expects adjusted EPS of $3.03 to $3.08. Analysts surveyed by FactSet expect $3.10.

The company expects net sales growth of 0% to 2% for the fiscal year. Analysts surveyed by FactSet expect $6.86 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canadian Natural Resources Lifts Quarterly Dividend 7%, Shares Up 0.2% in US Premarket Trading
Canadian Natural Resources Lifts Quarterly Dividend 7%, Shares Up 0.2% in US Premarket Trading
Oct 7, 2024
06:38 AM EDT, 10/07/2024 (MT Newswires) -- Canadian Natural Resources ( CNQ ) rose 0.2% in US premarket trading on Monday after saying it will boost its quarterly dividend 7% to $0.5625 per common share. The company said the dividend boost is in conjunction with the acquisition of Chevron Canada's (CVX) Alberta assets and as a result of its significant...
Pfizer Eyed By Starboard for Shareholder Rights Campaign
Pfizer Eyed By Starboard for Shareholder Rights Campaign
Oct 7, 2024
06:44 AM EDT, 10/07/2024 (MT Newswires) -- Pfizer ( PFE ) may become the target of a shareholder campaign led by Starboard Value, which has taken a $1 billion stake in the company, multiple news outlets reported Sunday. Reuters reported that Starboard, an activist investment advisory firm, wants to improve Pfizer's ( PFE ) performance and has already approached former...
dynaCERT Received Final Verra Approval of its Carbon Credit Methodology; Jumped 31% and Hit 52 Week Highs on Friday
dynaCERT Received Final Verra Approval of its Carbon Credit Methodology; Jumped 31% and Hit 52 Week Highs on Friday
Oct 7, 2024
06:45 AM EDT, 10/07/2024 (MT Newswires) -- dynaCERT (DYA.TO), which jumped more than 30% and hit fresh 52 week highs last Friday, over the weekend announced that it has received the final Verra approval of its Carbon Credit Methodology. In a statement dynaCert said this Verra-approved methodology marks a significant milestone in the company's ongoing business evolution, as it underscores...
CAMP4 Therapeutics seeks up to $283 mln valuation in US IPO
CAMP4 Therapeutics seeks up to $283 mln valuation in US IPO
Oct 7, 2024
Oct 7 (Reuters) - CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it was targeting a valuation of up to $283 million in its initial public offering in the United States. The company will join a pack of biotech firms that have listed their shares recently as a long-awaited policy-easing cycle begins. Startups are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved